FANCD2 Monoubiquitination in DNA Damage Responses
DNA 损伤反应中的 FANCD2 单泛素化
基本信息
- 批准号:7882617
- 负责人:
- 金额:$ 33.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-07-08 至 2013-06-30
- 项目状态:已结题
- 来源:
- 关键词:Acute Myelocytic LeukemiaAddressApoptosisCD34 geneCell physiologyCellsChromosomal InstabilityChromosome abnormalityComplexCoupledCrosslinkerDNADNA DamageDNA RepairDNA biosynthesisDefectDetectionDiseaseDysmyelopoietic SyndromesFanconi anemia proteinFanconi&aposs AnemiaGeneral PopulationGenesGoalsHematopoiesisHematopoieticHumanHypersensitivityLeadLightLinkMCM7 geneMalignant NeoplasmsMediatingMicroscopyMitomycinsMolecularMonoubiquitinationMusMutateMyelogenousNormal CellNuclearPancytopeniaPathogenesisPathway interactionsPatientsPhenotypePhosphotransferasesPredispositionPrevalenceProteinsRecruitment ActivityRegulationResistanceRoleSiteStem cellsStressStudy SectionSystemTimebaseclinical phenotypeinsightleukemiamutantpreventprogenitorprotein functionreconstitutionresponsesensorsmall hairpin RNAstem
项目摘要
DESCRIPTION (provided by applicant): Fanconi Anemia (FA) is a multi-genic disorder that results in progressive bone marrow failure and a strong predisposition to myelodysplastic syndrome and leukemia. FA proteins are involved in the cellular response to DNA damage by a largely unknown mechanism. A nuclear complex of at least 8 FA proteins is required for the monoubiquitination of FANCD2. Monoubiquitination of FANCD2 is required for resistance to the crosslinker mitomycin C. The ATR checkpoint kinase also regulates FANCD2 monoubiquitination and potentially links FANCD2 to the detection of DNA damage at the replication fork. The goal of this study is to understand the regulation and function of FANCD2 monoubiquitination, and thereby to better understand the collective role of FA proteins in promoting normal hematopoiesis. Certain FA proteins are mutated in spontaneous cancers in the general population, so these studies are also relevant to understanding how cancer develops. The specific aims of the study are as follows: 1) Delineate mechanisms of the ATR-dependent regulation of FANCD2 monoubiquitination. How, and whether, MCM7 and Rad17, along with Rad9, cooperate to couple FANCD2 monoubiquitination to the detection of DNA damage at the replication fork will be determined. ShRNA-mediated suppression of these proteins in primary human CD34+ cells, and expression of mutants in an immortalized myeloid precursor line, will be utilized. Whether these DNA damage sensors prevent chromosomal instability and apoptosis in response to MMC will also be determined. 2) Determine whether defects in FANCD2 monoubiquitination and the assembly of FANCD2 foci results in chromosomal instability and sensitivity to MMC in CD34+ hematopoietic stem/progenitor cells. FANCD2 monoubiquitination will be inhibited by shRNA-mediated suppression of FANCA. Also, mechanisms involved in the recruitment of FANCD2 to blocked replication forks will be elucidated using real-time microscopy in cells reconstituted with EGFP- FANCD2. PROJECT NARRATIVE It is increasingly clear that alterations in some Fanconi anemia pathway proteins are involved in some spontanous cancers seen in the general population. Thus the studies described in this application may shed new light on both normal and abnormal stem cell function and on cancer formation.
描述(由申请人提供): 范可尼贫血(FA)是一种多基因疾病,可导致进行性骨髓衰竭,并具有患骨髓增生异常综合征和白血病的强烈倾向。FA蛋白通过一种很大程度上未知的机制参与细胞对DNA损伤的反应。FANCD 2的单泛素化需要至少8个FA蛋白的核复合物。FANCD 2的单泛素化是抵抗交联剂丝裂霉素C所必需的。ATR检查点激酶还调节FANCD 2单泛素化,并可能将FANCD 2与复制叉处的DNA损伤检测联系起来。本研究的目的是了解FANCD 2单胞诱导的调节和功能,从而更好地了解FA蛋白在促进正常造血中的集体作用。某些FA蛋白在一般人群中的自发性癌症中发生突变,因此这些研究也与了解癌症如何发展有关。本研究的具体目的如下:1)阐明FANCD 2单泛素化的ATR依赖性调控机制。将确定MCM 7和Rad 17以及Rad 9沿着如何以及是否合作以将FANCD 2单泛素化偶联到复制叉处的DNA损伤的检测。将利用shRNA介导的这些蛋白在原代人CD 34+细胞中的抑制,以及突变体在永生化髓样前体细胞系中的表达。这些DNA损伤传感器是否防止染色体不稳定性和细胞凋亡,以应对MMC也将被确定。2)确定FANCD 2单泛素化和FANCD 2聚集点的组装缺陷是否会导致CD 34+造血干/祖细胞的染色体不稳定性和对MMC的敏感性。FANCD 2单泛素化将被shRNA介导的FANCA抑制所抑制。此外,将在用EGFP-FANCD 2重建的细胞中使用实时显微镜来阐明FANCD 2招募到被阻断的复制叉的机制。越来越清楚的是,一些范可尼贫血途径蛋白的改变与普通人群中观察到的一些自发性癌症有关。因此,本申请中描述的研究可能会对正常和异常干细胞功能以及癌症形成提供新的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PAUL R ANDREASSEN其他文献
PAUL R ANDREASSEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PAUL R ANDREASSEN', 18)}}的其他基金
Functional characterization of the role of distinct domains of ATM and the impact of sequence variants on the DNA damage response
ATM 不同结构域的功能特征以及序列变异对 DNA 损伤反应的影响
- 批准号:
9796835 - 财政年份:2019
- 资助金额:
$ 33.75万 - 项目类别:
Functional characterization of the role of distinct domains of ATM and the impact of sequence variants on the DNA damage response
ATM 不同结构域的功能特征以及序列变异对 DNA 损伤反应的影响
- 批准号:
10436183 - 财政年份:2019
- 资助金额:
$ 33.75万 - 项目类别:
Functional characterization of the role of distinct domains of ATM and the impact of sequence variants on the DNA damage response
ATM 不同结构域的功能特征以及序列变异对 DNA 损伤反应的影响
- 批准号:
10166885 - 财政年份:2019
- 资助金额:
$ 33.75万 - 项目类别:
14th Annual Midwest DNA Repair Symposium
第 14 届年度中西部 DNA 修复研讨会
- 批准号:
8319116 - 财政年份:2012
- 资助金额:
$ 33.75万 - 项目类别:
FANCD2 Monoubiquitination in DNA Damage Responses
DNA 损伤反应中的 FANCD2 单泛素化
- 批准号:
7837429 - 财政年份:2009
- 资助金额:
$ 33.75万 - 项目类别:
FANCD2 Monoubiquitination in DNA Damage Responses
DNA 损伤反应中的 FANCD2 单泛素化
- 批准号:
7652332 - 财政年份:2008
- 资助金额:
$ 33.75万 - 项目类别:
FANCD2 Monoubiquitination in DNA Damage Responses
DNA 损伤反应中的 FANCD2 单泛素化
- 批准号:
8296565 - 财政年份:2008
- 资助金额:
$ 33.75万 - 项目类别:
FANCD2 Monoubiquitination in DNA Damage Responses
DNA 损伤反应中的 FANCD2 单泛素化
- 批准号:
7528962 - 财政年份:2008
- 资助金额:
$ 33.75万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 33.75万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 33.75万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 33.75万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 33.75万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 33.75万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 33.75万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 33.75万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 33.75万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 33.75万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 33.75万 - 项目类别:
Research Grant